Reims, France · Founded 2019 · Privately Held (backing)
Developer of peptide-based biotechnology designed to provide therapeutic strategies for multiple types of cancer. Apmonia Therapeutics is based in Reims, France and was founded in 2019. Its last reported valuation was $26.8 million in Oct 2025. It has raised $23.9 million.
Last reported valuation
$26.8M
Oct 2026
Priced at
—
Total raised
$23.9M
Last round
—
Team — not yet on record
No current team members for Apmonia Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Apmonia Therapeutics with a free account
·The complete investor list: 12 names
·Watch Apmonia Therapeutics: the Monday email on marks, rounds and moves
